In this article
Check out the companies making headlines in midday trading.
Bausch Health – Trading in the pharmaceutical company's shares was halted after the stock dipped 50%. A Delaware federal court judge issued an oral order regarding patent litigation over Xifaxan, Bausch's drug that treats irritable bowel syndrome and diarrhea. The order could pave the way for generic competition for the drug in the late 2024 to 2025 time frame, according to JPMorgan. The bank downgraded Bausch on the litigation update, dropping its rating to neutral from overweight.
Wingstop – The fast casual restaurant chain's shares surged 20.18% following an earnings beat in the second quarter. Wingstop posted adjusted earnings of 45 cents per share, and topped estimates of 36 cents, according to Refinitiv. The company missed revenue estimates but reaffirmed its guidance for the full year.
Meta Platforms – Shares of the Facebook parent company slid 5.22% on the back of disappointing quarterly results. Meta Platforms posted a miss on the top and bottom lines in the second quarter as digital advertising slowed. The company also issued a weak forecast for the current period.
Comcast – The cable and entertainment giant's shares slid 9.13% despite the company posting strong quarterly earnings and revenue. Comcast failed to add broadband subscribers in the quarter for the first time ever. The company said it lost 30,000 broadband subscribers this month alone.
Qualcomm – Shares of the chipmaker fell 4.54% after the company issued guidance for the current quarter that was short of consensus expectations. Qualcomm's forecast suggested that the company's handset sales growth would slow during its fiscal fourth quarter, reflecting a decline in smartphone
Read more on cnbc.com